For example, Valenti et al. have reported that providing treatment with phlebotomy improved insulin resistance in patients with NAFLD who had mutations in the HFE gene for hereditary hemochromatosis that led to hyperferritinemia (Valenti et al., 2007). This evidence concerns the gene HFE and metabolic dysfunction-associated steatotic liver disease.